This meta-analysis indicated that loss of syndecan-1 expression is associated with CRC development, histological differentiation, and clinical stage, but not with lymph node metastasis and distant metastasis. The gene discussed is SDC1; the disease is metastatic malignant neoplasm in the lymph nodes.